(Q42657184)

English

Twenty-four-month alpha-galactosidase A replacement therapy in Fabry disease has only minimal effects on symptoms and cardiovascular parameters

scientific article published on 23 May 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Twenty-four-month alpha-galactosidase A replacement therapy in Fabry disease has only minimal effects on symptoms and cardiovascular parameters (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

circulatory system

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

author name string

J W Koskenvuo

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

J J Hartiala

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

P Nuutila

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

R Kalliokoski

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

J S Viikari

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

E Engblom

6

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

M Penttinen

7

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

I Mononen

9

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

I M Kantola

10

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

publication date

23 May 2008

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Journal of Inherited Metabolic Disease

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

432-441

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study

1 reference

https://api.crossref.org/works/10.1007%2FS10545-008-0848-3

21 January 2018

Determinants of echocardiographic aortic root size. The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1007%2FS10545-008-0848-3

21 January 2018

An Atypical Variant of Fabry's Disease with Manifestations Confined to the Myocardium

1 reference

https://api.crossref.org/works/10.1007%2FS10545-008-0848-3

21 January 2018

Transesophageal Echocardiography

1 reference

https://api.crossref.org/works/10.1007%2FS10545-008-0848-3

21 January 2018

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fabry's disease cardiomyopathy: echocardiographic detection of endomyocardial glycosphingolipid compartmentalization

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fabry disease: overall effects of agalsidase alfa treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired myocardial perfusion reserve but preserved peripheral endothelial function in patients with Fabry disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme replacement therapy with agalsidase alfa in children with Fabry disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with alpha galactosidase A

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme replacement therapy in Fabry disease: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical benefit of enzyme replacement therapy in Fabry disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fabry disease: a functional and anatomical study of cardiac manifestations in 20 hemizygous male patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence and Clinical Significance of Cardiac Arrhythmia in Anderson-Fabry Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New ergometric reference values for clinical exercise tests

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A practical guide to assessment of ventricular diastolic function using Doppler echocardiography

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative determination of globotriaosylceramide by immunodetection of glycolipid-bound recombinant verotoxin B subunit

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thirty-four novel mutations of the GLA gene in 121 patients with Fabry disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of lysosomal storage disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is left ventricular mass in apparently healthy, normotensive men correlated to maximal blood pressure during exercise?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement in serial cardiopulmonary exercise testing following enzyme replacement therapy in Fabry disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme therapy for Fabry disease: neutralizing antibodies toward agalsidase alpha and beta

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac MRI: accuracy of simultaneous measurement of left and right ventricular parameters using three different sequences

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure: the Beta-blocker Evaluation of Survival Trial (BEST)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The right ventricle in Fabry disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ambulatory blood pressure: normality and comparison with other measurements. Hypertension Working Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Electrocardiograms in Fabry's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New insights in cardiac structural changes in patients with Fabry’s disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac valvular anomalies in Fabry disease. Clinical, morphologic, and biochemical studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Electrophysiologic findings in Fabry's disease with a short PR interval

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme replacement therapy in Fabry disease patients undergoing dialysis: effects on quality of life and organ involvement.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Echocardiographic abnormalities and disease severity in Fabry's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Normal limits of the electrocardiogram in a Chinese population

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Agalsidase-beta therapy for advanced Fabry disease: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of 12-month enzyme replacement therapy on myocardial perfusion in patients with Fabry disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High incidence of later-onset fabry disease revealed by newborn screening

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of uncontrolled hypertension in patients with Fabry disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10545-008-0848-3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42657184&oldid=2205585784"